Novavax and SII seek WHO emergency use listing for Covid-19 vaccine
WHO authorisation is a prerequisite to supply the vaccine to several countries that are part of the COVAX Facility.
Infectious Diseases
Why has the WHO asked governments to delay Covid-19 booster jabs?
While booster shots will likely be needed long-term, the WHO has argued that first jabs...
Tonix and Columbia University to develop specialised Covid-19 vaccines
The alliance plans to isolate therapeutically significant fully human neutralising monoclonal antibodies against Covid-19.
Will Covid-19 vaccines be approved for young children?
Some vaccine makers are seeking regulatory approval for children younger than 12 years old.
Clover Biopharmaceuticals’ Covid-19 jab could help boost global vaccine supply
The clinical-stage company has announced that its Covid-19 vaccine candidate, SCB-2019, is 67% effective against...
Immunic signs agreement to in-license assets to treat viral infections
A combination of DHODH inhibitor, IMU-838 and N4-hydroxycytidine offered a decline in viral RNA to undetectable levels.
FDA approves Pfizer Covid vaccine booster shot for older population
A third vaccine dose is intended for people at high risk and those prone to institutional or occupational exposure to the virus.
Big pharma fuelling human rights crisis over Covid-19 vaccine inequity, says Amnesty
The human rights group has accused the world’s leading vaccine makers of failing to allocate doses fairly across the globe.
Lilly signs deal to supply Covid-19 antibody combo to European countries
On obtaining approval in Europe, participating nations in the EU and EEA can buy the antibodies directly from Lilly.
Merck and Ridgeback’s molnupiravir rollout difficult to map in uncertain Covid-19 landscape
Questions about oral molnupiravir's deployment still loom large as clinicians await crucial late-stage trial results.
J&J’s data confirms robust and durable protection of Covid-19 vaccine
Antibody levels increased to 12-fold after four weeks of administering a booster shot of the vaccine, the study showed.
